• 1
    Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002; 111: 4150.
  • 2
    Zhu Y, Stevens RG, Leaderer D, Hoffman A, Holford T, Zhang Y, Brown HN, Zheng T. Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk. Breast Cancer Res Treat 2008; 107: 4215.
  • 3
    You S, Wood PA, Xiong Y, Kobayashi M, Du-Quiton J, Hrushesky WJ. Daily coordination of cancer growth and circadian clock gene expression. Breast Cancer Res Treat 2005; 91: 4760.
  • 4
    Hua H, Wang Y, Wan C, Liu Y, Zhu B, Wang X, Wang Z, Ding JM. Inhibition of tumorigenesis by intratumoral delivery of the circadian gene mPer2 in C57BL/6 mice. Cancer Gene Ther 2007; 14: 8158.
  • 5
    Filipski E, King VM, Li X, Granda TG, Mormont MC, Liu X, Claustrat B, Hastings MH, Levi F. Host circadian clock as a control point in tumor progression. J Natl Cancer Inst 2002; 94: 6907.
  • 6
    Stevens RG. Circadian disruption and breast cancer: from melatonin to clock genes. Epidemiology 2005; 16: 2548.
  • 7
    Lahti TA, Partonen T, Kyyronen P, Kauppinen T, Pukkala E. Night-time work predisposes to non-Hodgkin lymphoma. Int J Cancer 2008; 123: 214851.
  • 8
    Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science 2003; 302: 2559.
  • 9
    Koyanagi S, Kuramoto Y, Nakagawa H, Aramaki H, Ohdo S, Soeda S, Shimeno H. A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res 2003; 63: 727783.
  • 10
    Walters JF, Hampton SM, Deanfield JE, Donald AE, Skene DJ, Ferns GA. Circadian variation in endothelial function is attenuated in postmenopausal women. Maturitas 2006; 54: 294303.
  • 11
    Wood PA, Du-Quiton J, You S, Hrushesky WJ. Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index. Mol Cancer Ther 2006; 5: 202333.
  • 12
    Lowrey PL, Takahashi JS. Mammalian circadian biology: elucidating genome-wide levels of temporal organization. Annu Rev Genomics Hum Genet 2004; 5: 40741.
  • 13
    Wilsbacher LD, Yamazaki S, Herzog ED, Song EJ, Radcliffe LA, Abe M, Block G, Spitznagel E, Menaker M, Takahashi JS. Photic and circadian expression of luciferase in mPeriod1-luc transgenic mice in vivo. Proc Natl Acad Sci USA 2002; 99: 48994.
  • 14
    Contag CH, Jenkins D, Contag FR, Negrin RS. Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia 2000; 2: 4152.
  • 15
    Browder T, Butterfield CE, Kraling BM, Shi B, Marshall B, O'Reilly MS, Folkman J. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res 2000; 60: 187886.
  • 16
    Meert AP, Paesmans M, Martin B, Delmotte P, Berghmans T, Verdebout JM, Lafitte JJ, Mascaux C, Sculier JP. The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer 2002; 87: 694701.
  • 17
    Ahmed F, Steele JC, Herbert JM, Steven NM, Bicknell R. Tumor stroma as a target in cancer. Curr Cancer Drug Targets 2008; 8: 44753.
  • 18
    Bertram JS, Janik P. Establishment of a cloned line of Lewis Lung Carcinoma cells adapted to cell culture. Cancer Lett 1980; 11: 6373.
  • 19
    Mayo JG. Biologic characterization of the subcutaneously implanted Lewis lung tumor. Cancer Chemother Rep 2 1972; 3: 32530.
  • 20
    O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79: 31528.
  • 21
    Ishida T, Kundu RK, Yang E, Hirata K, Ho YD, Quertermous T. Targeted disruption of endothelial cell-selective adhesion molecule inhibits angiogenic processes in vitro and in vivo. J Biol Chem 2003; 278: 34598604.
  • 22
    Shen R, Ye Y, Chen L, Yan Q, Barsky SH, Gao JX. Precancerous stem cells can serve as tumor vasculogenic progenitors. PLoS ONE 2008; 3: e1652.
  • 23
    Kataki A, Scheid P, Piet M, Marie B, Martinet N, Martinet Y, Vignaud JM. Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression. J Lab Clin Med 2002; 140: 3208.
  • 24
    Palm D, Entschladen F. Neoneurogenesis and the neuro-neoplastic synapse. Prog Exp Tumor Res 2007; 39: 918.
  • 25
    Lundkvist GB, Kwak Y, Davis EK, Tei H, Block GD. A calcium flux is required for circadian rhythm generation in mammalian pacemaker neurons. J Neurosci 2005; 25: 76826.
  • 26
    Collaco AM, Geusz ME. Monitoring immediate-early gene expression through firefly luciferase imaging of HRS/J hairless mice. BMC Physiology 2003; 3: 8.
  • 27
    Davidson AJ, London B, Block GD, Menaker M. Cardiovascular tissues contain independent circadian clocks. Clin Exp Hypertens 2005; 27: 30711.
  • 28
    Dong Z, Kumar R, Yang X, Fidler IJ. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 1997; 88: 80110.
  • 29
    Lowrey PL, Takahashi JS. Genetics of the mammalian circadian system: Photic entrainment, circadian pacemaker mechanisms, and posttranslational regulation. Annu Rev Genet 2000; 34: 53362.
  • 30
    Albrecht U, Sun ZS, Eichele G, Lee CC. A differential response of two putative mammalian circadian regulators, mper1 and mper2, to light. Cell 1997; 91: 105564.
  • 31
    Shigeyoshi Y, Taguchi K, Yamamoto S, Takekida S, Yan L, Tei H, Moriya T, Shibata S, Loros JJ, Dunlap JC, Okamura H. Light-induced resetting of a mammalian circadian clock is associated with rapid induction of the mPer1 transcript. Cell 1997; 91: 104353.
  • 32
    Field MD, Maywood ES, O'Brien JA, Weaver DR, Reppert SM, Hastings MH. Analysis of clock proteins in mouse SCN demonstrates phylogenetic divergence of the circadian clockwork and resetting mechanisms. Neuron 2000; 25: 43747.
  • 33
    Beaule C, Amir S. The eyes suppress a circadian rhythm of FOS expression in the suprachiasmatic nucleus in the absence of light. Neuroscience 2003; 121: 2537.
  • 34
    Masubuchi S, Kataoka N, Sassone-Corsi P, Okamura H. Mouse Period1 (mPER1) acts as a circadian adaptor to entrain the oscillator to environmental light/dark cycles by regulating mPER2 protein. J Neurosci 2005; 25: 471924.
  • 35
    Castillo MR, Hochstetler KJ, Tavernier RJ,Jr., Greene DM, Bult-Ito A. Entrainment of the master circadian clock by scheduled feeding. Am J Physiol Regul Integr Comp Physiol 2004; 287: R5515.
  • 36
    Yan L, Silver R. Resetting the brain clock: time course and localization of mPER1 and mPER2 protein expression in suprachiasmatic nuclei during phase shifts. Eur J Neurosci 2004; 19: 11059.
  • 37
    Jilg A, Moek J, Weaver DR, Korf HW, Stehle JH, von Gall C. Rhythms in clock proteins in the mouse pars tuberalis depend on MT1 melatonin receptor signalling. Eur J Neurosci 2005; 22: 284554.
  • 38
    Eyden B. Smooth-muscle-type myofilaments and actin in reactive and neoplastic nonmuscle cells. Ultrastruct Pathol 2000; 24: 34751.
  • 39
    Chalmers JA, Martino TA, Tata N, Ralph MR, Sole MJ, Belsham DD. Vascular circadian rhythms in a mouse vascular smooth muscle cell line (Movas-1). Am J Physiol Regul Integr Comp Physiol 2008; 295: R152938.
  • 40
    Zambon AC, McDearmon EL, Salomonis N, Vranizan KM, Johansen KL, Adey D, Takahashi JS, Schambelan M, Conklin BR. Time- and exercise-dependent gene regulation in human skeletal muscle. Genome Biol 2003; 4: R61.
  • 41
    Seruga B, Zhang H, Bernstein LJ, Tannock IF. Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer 2008; 8: 88799.
  • 42
    Cavadini G, Petrzilka S, Kohler P, Jud C, Tobler I, Birchler T, Fontana A. TNF-alpha suppresses the expression of clock genes by interfering with E-box-mediated transcription. Proc Natl Acad Sci USA 2007; 104: 128438.
  • 43
    Pittendrigh CS, Daan S. A functional analysis of circadian pacemakers in nocturnal rodents. 1. The stability and lability of spontaneous frequency. J Comp Physiol A 1976; 106: 22352.
  • 44
    Hughes AT, Guilding C, Lennox L, Samuels RE, McMahon DG, Piggins HD. Live imaging of altered period1 expression in the suprachiasmatic nuclei of Vipr2-/- mice. J Neurochem 2008; 106: 164657.
  • 45
    Rosbash M, Takahashi JS. Circadian rhythms: the cancer connection. Nature 2002; 420: 3734.
  • 46
    Fu L, Lee CC. The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer 2003; 3: 35061.
  • 47
    Canaple L, Kakizawa T, Laudet V. The days and nights of cancer cells. Cancer Res 2003; 63: 754552.
  • 48
    Filipski E, King VM, Li X, Granda TG, Mormont MC, Claustrat B, Hastings MH, Levi F. Disruption of circadian coordination accelerates malignant growth in mice. Pathol Biol (Paris) 2003; 51: 2169.
  • 49
    Filipski E, Delaunay F, King VM, Wu MW, Claustrat B, Grechez-Cassiau A, Guettier C, Hastings MH, Francis L. Effects of chronic jet lag on tumor progression in mice. Cancer Res 2004; 64: 787985.
  • 50
    Wu MW, Li XM, Xian LJ, Levi F. Effects of meal timing on tumor progression in mice. Life Sci 2004; 75: 118193.
  • 51
    Reddy AB, Wong GK, O'Neill J, Maywood ES, Hastings MH. Circadian clocks: neural and peripheral pacemakers that impact upon the cell division cycle. Mutat Res 2005; 574: 7691.
  • 52
    Burns ER, Scheving LE, Tsai TH. Circadian rhythms in DNA synthesis and mitosis in normal mice and mice bearing the Lewis lung carcinoma. Eur J Cancer 1979; 15: 43342.
  • 53
    Balsalobre A, Marcacci L, Schibler U. Multiple signaling pathways elicit circadian gene expression in cultured Rat-1 fibroblasts. Current Biology 2000; 10: 12914.
  • 54
    Akiyama M, Minami Y, Nakajima T, Moriya T, Shibata S. Calcium and pituitary adenylate cyclase-activating polypeptide induced expression of circadian clock gene mPer1 in the mouse cerebellar granule cell culture. J Neurochem 2001; 78: 499508.
  • 55
    Yokota S, Yamamoto M, Moriya T, Akiyama M, Fukunaga K, Miyamoto E, Shibata S. Involvement of calcium-calmodulin protein kinase but not mitogen-activated protein kinase in light-induced phase delays and Per gene expression in the suprachiasmatic nucleus of the hamster. J Neurochem 2001; 77: 61827.
  • 56
    Travnickova-Bendova Z, Cermakian N, Reppert SM, Sassone-Corsi P. Bimodal regulation of mPeriod promoters by CREB-dependent signaling and CLOCK/BMAL1 activity. Proc Natl Acad Sci USA 2002; 99: 772833.
  • 57
    Nomura K, Takeuchi Y, Yamaguchi S, Okamura H, Fukunaga K. Involvement of calcium/calmodulin-dependent protein kinase II in the induction of mPer1. J Neurosci Res 2003; 72: 38492.
  • 58
    Siu YT, Jin DY. CREB--a real culprit in oncogenesis. FEBS J 2007; 274: 322432.
  • 59
    Numano R, Yamazaki S, Umeda N, Samura T, Sujino M, Takahashi R, Ueda M, Mori A, Yamada K, Sakaki Y, Inouye ST, Menaker M, et al. Constitutive expression of the Period1 gene impairs behavioral and molecular circadian rhythms. Proc Natl Acad Sci USA 2006; 103: 371621.
  • 60
    Garcia-Fernandez JM, Alvarez-Lopez C, Cernuda-Cernuda R. Cytoplasmic localization of mPER1 clock protein isoforms in the mouse retina. Neurosci Lett 2007; 419: 558.
  • 61
    Arjona A, Sarkar DK. The circadian gene mPer2 regulates the daily rhythm of IFN-gamma. J Interferon Cytokine Res 2006; 26: 6459.
  • 62
    Arjona A, Sarkar DK. Circadian oscillations of clock genes, cytolytic factors, and cytokines in rat NK cells. J Immunol 2005; 174: 761824.